Topics

Companies Related to "Genome editing startup Beam Therapeutics already trying public" [Most Relevant Company Matches] RSS

03:48 EST 14th December 2019 | BioPortfolio

Here are the most relevant search results for "Genome editing startup Beam Therapeutics already trying public" found in our extensive corporate database of over 50,000 company records.

Showing "Genome editing startup Beam Therapeutics already trying public" Companies 1–25 of 4,000+

Extremely Relevant

Beam Therapeutics

Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam is pursuing therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Headquartered in Cambridge, Massachusetts, the company is bac...


Editas Medicine

Editas Medicine is a transformative genome editing company founded by five world leaders in the fields of genome editing, protein engineering, and molecular and structural biology, with specific expertise in CRISPR/Cas9 and TALENs technologies. The company’s mission is to translate its genome editing technology into a novel class of human therapeutics...

Relevant

COBO Technologies

COBO Technologies is a fast-growing CRO specialised in services and products for quality control of genome editing applications in research and clinical fields. The company supports customers globally with detailed DNA mutation analysis and complexed protein expression profiling of cells, plants or animals modified with genome editing tools such as Meganucleases CRISPR-Cas9, ZFNs and TALENs.


LogicBio Therapeutics, Inc.

Launched in 2016, LogicBio is a leading genome-editing company founded by pioneers in gene therapy from Stanford University, with a mission to develop transformative medicines for life-threatening diseases. Its GeneRide™ technology enables highly specific genome editing and integration of the therapeutic transgene, utilizing the body's own native proc...

E-BEAM Services

E-BEAM Services, Inc. is a leading supplier of contract electron beam processing services, with more than 450kW of installed accelerator capacity -- enough to process nearly one billion pounds of material annually.Based in Cranbury, NJ, E-BEAM was incorporated in 1985 to acquire the radiation service division of a subsidiary of Monsanto.E-BEAM is a privately owned corporation with over 50 employee...

Sangamo Therapeutics, Inc.

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com

Personal Genome Project

The Personal Genome Project is an open-ended research study that aims to improve the understanding of genetic and environmental contributions to human traits. The project is currently enrolling members of the public who are willing to share their genome sequence and other personal information with the scientific community and the general public. For more i...

Shape Therapeutics, Inc.

Shape Therapeutics, Inc. is creating the world’s leading RNA and protein targeting platforms focused on the cure of human diseases. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). The RNAfix™ technology allows for the editing of RNA using natural human cell...

Precision BioSciences Inc.

Precision BioSciences’ mission is to continually provide, improve, and enable the world’s most powerful genome engineering technology. Precision’s proprietary Directed Nuclease EditorTM (DNE) technology enables the production of genome editing enzymes that can insert, remove, modify, and regulate essentially any gene in mammalian or plant ce...

Suitable Technologies, Inc.

The Suitable Technologies Beam product family revolutionizes remote interaction by combining user-controlled device mobility with professional video conferencing for an immersive communication experience. The freedom to select their own path through an environment enables Beam users to be present and to interact naturally from anywhere in the world. Founde...

Repare Therapeutics, Inc.

Repare Therapeutics is pioneering synthetic lethality to develop novel therapeutics that target specific vulnerabilities of tumors in clearly defined patient populations. The company’s initial focus is on novel targeted therapies in cancer types harboring defective DNA-damage response (DDR)- or genome instability-related functions. Repare’s SNIPR...

English Manager Science Editing

English Manager Science Editing is an Australian business that aims to provide a fast, efficient excellent-quality English language scientific editing service using the Internet. We use experienced freelance scientific editors with diverse backgrounds. Dr. Scott Butler - Managing EditorScott completed his Ph.D. in 1995 in the Department of Theoretical Chemistry at the University of Sydney. Subsequ...

Beam Global Spirits & Wine, Inc.

Inspiring conversations around the world, Beam Global Spirits & Wine, Inc. is building brands people want to talk about. Consumers from all corners of the globe call for our brands, including Jim Beam(R) Bourbon, Sauza(R) Tequila, Canadian Club(R) Whisky, Courvoisier(R) Cognac, Maker's Mark(R) Bourbon, Laphroaig(R) Scotch Whisky, Cruzan(R) Rum, Larios(R) Gin, Whisky DYC(R), Teacher's(R) Scotch Whi...

Beam Global Spirits & Wine

Inspiring conversations around the world, Beam Global Spirits & Wine, Inc. is building brands people want to talk about. Consumers from all corners of the globe call for our brands, including Jim Beam(R) Bourbon, Sauza(R) Tequila, Canadian Club(R) Whisky, Courvoisier(R) Cognac, Maker's Mark(R) Bourbon, Laphroaig(R) Scotch Whisky, Cruzan(R) Rum, EFFEN(R) Vodka, Larios(R) Gin, Whisky DYC(R), Teacher...

eGenesis

eGenesis is a life sciences company focused on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues and organs to the hundreds of thousands of patients worldwide who are in dire need. For more information, please visit www.egenesisbio.com.

Inscripta

Inscripta is a gene editing technology company that puts researchers in control by making it easy for them to get all they need for cutting-edge, single cell engineering. These tools include a family of CRISPR enzymes (called MADzymes), custom nucleases for researchers and commercial partners, and a full suite of gene editing tools (instruments, reagents, ...

Intellia Therapeutics, Inc.

Intellia Therapeutics is a leading gene-editing company focused on the development of proprietary products utilizing the recently discovered CRISPR/Cas9 technology. Intellia intends to advance its pipeline and potentially develop a new drug class by leveraging its leading scientific and clinical development expertise and its exclusive access to one of the ...

CRISPR Therapeutics

CRISPR Therapeutics is a biopharmaceutical company created to translate CRISPR-Cas9, a breakthrough gene-editing technology, into transformative medicines for serious human genetic diseases. Its vision is to cure serious human diseases at the molecular level using CRISPR-Cas9. CRISPR Therapeutics is a Swiss company with operations in London, UK. www.crisprtx.com ...

EBS

Energy Beam Sciences designs, manufactures, and sells quality products for histology, light microscopy, electron microscopy, materials sciences, and the production, control and application of electron beam technology

GenEdit, Inc.

GenEdit was founded to transform the delivery of gene and gene editing therapies. We have synthesized the NanoGalaxy™ library of polymers that can encapsulate RNA, DNA, protein and/or RNP. Through advanced screening methods, computational analysis and iterative medicinal chemistry, we have demonstrated efficient delivery of gene editing cargo to specific tissues. We seek development partners...

Strand Therapeutics Inc.

Strand Therapeutics is an early-stage biotechnology company genetically programming revolutionary therapies to improve the lives of patients. Through pioneering work developed at MIT, Strand is building the world’s first smart mRNA therapeutics. Strand is expanding their innovative and rapidly expanding team that understands the value of working at a ...

Takara Bio USA, Inc.

Takara Bio USA, Inc. (TBUSA; formerly Clontech Laboratories, Inc.) is a wholly owned subsidiary of Takara Bio Inc. that manufactures and distributes kits, reagents, and instruments for life sciences research applications, including NGS, PCR, gene delivery, genome editing, stem cell research, nucleic acid and protein purification, and automated sampl...

Genome Therapeutics Corporation

Genome Therapeutics Corp. is a leader in the field of genomics-based drug targets discovery -- the identification andfunctional characterization of genes. The Company has over ten years of experience in positional cloning, having served as one of the primary researchers under genome programs sponsored by the United States government, and has developed numerous techniques and tools that are widely ...

Precision BioSciences, Inc.

Precision's mission is to utilize its engineered endonuclease technology to become the world leader in the field of genomic molecular biology. Precision’s proprietary Directed Nuclease EditorTM (DNE) technology enables the production of custom genome editing enzymes that can insert, remove, modify, and regulate essentially any gene in mammalian or pla...

Inscripta, Inc.

Inscripta is developing the world's first benchtop platform for scalable Digital Genome Engineering. The company’s advanced CRISPR-based platform, consisting of an instrument, reagents, and software, will offer a fully automated workflow that enables multiplexed, trackable editing of cells at an unprecedented scale. Inscripta’s goal is to empower scientists whose gene editing research i...


More From BioPortfolio on "Genome editing startup Beam Therapeutics already trying public"

Quick Search

Corporate Database Quicklinks